
OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Radiotherapy and immunotherapy: a beneficial liaison?
Ralph R. Weichselbaum, Hua Liang, Liufu Deng, et al.
Nature Reviews Clinical Oncology (2017) Vol. 14, Iss. 6, pp. 365-379
Closed Access | Times Cited: 880
Ralph R. Weichselbaum, Hua Liang, Liufu Deng, et al.
Nature Reviews Clinical Oncology (2017) Vol. 14, Iss. 6, pp. 365-379
Closed Access | Times Cited: 880
Showing 1-25 of 880 citing articles:
Tumour-intrinsic resistance to immune checkpoint blockade
Anusha Kalbasi, Antoni Ribas
Nature reviews. Immunology (2019) Vol. 20, Iss. 1, pp. 25-39
Open Access | Times Cited: 1181
Anusha Kalbasi, Antoni Ribas
Nature reviews. Immunology (2019) Vol. 20, Iss. 1, pp. 25-39
Open Access | Times Cited: 1181
Cancer nanomedicine for combination cancer immunotherapy
Jutaek Nam, Sejin Son, Kyong Soo Park, et al.
Nature Reviews Materials (2019) Vol. 4, Iss. 6, pp. 398-414
Closed Access | Times Cited: 817
Jutaek Nam, Sejin Son, Kyong Soo Park, et al.
Nature Reviews Materials (2019) Vol. 4, Iss. 6, pp. 398-414
Closed Access | Times Cited: 817
Radiotherapy toxicity
Dirk De Ruysscher, Gabriele Niedermann, N.G. Burnet, et al.
Nature Reviews Disease Primers (2019) Vol. 5, Iss. 1
Closed Access | Times Cited: 652
Dirk De Ruysscher, Gabriele Niedermann, N.G. Burnet, et al.
Nature Reviews Disease Primers (2019) Vol. 5, Iss. 1
Closed Access | Times Cited: 652
Safety and Clinical Activity of Pembrolizumab and Multisite Stereotactic Body Radiotherapy in Patients With Advanced Solid Tumors
Jason J. Luke, Jeffrey M. Lemons, Theodore Karrison, et al.
Journal of Clinical Oncology (2018) Vol. 36, Iss. 16, pp. 1611-1618
Open Access | Times Cited: 524
Jason J. Luke, Jeffrey M. Lemons, Theodore Karrison, et al.
Journal of Clinical Oncology (2018) Vol. 36, Iss. 16, pp. 1611-1618
Open Access | Times Cited: 524
A general strategy towards personalized nanovaccines based on fluoropolymers for post-surgical cancer immunotherapy
Jun Xu, Jia Lv, Qi Zhuang, et al.
Nature Nanotechnology (2020) Vol. 15, Iss. 12, pp. 1043-1052
Open Access | Times Cited: 448
Jun Xu, Jia Lv, Qi Zhuang, et al.
Nature Nanotechnology (2020) Vol. 15, Iss. 12, pp. 1043-1052
Open Access | Times Cited: 448
Manganese Oxide Nanomaterials: Synthesis, Properties, and Theranostic Applications
Binbin Ding, Pan Zheng, Ping’an Ma, et al.
Advanced Materials (2020) Vol. 32, Iss. 10
Closed Access | Times Cited: 435
Binbin Ding, Pan Zheng, Ping’an Ma, et al.
Advanced Materials (2020) Vol. 32, Iss. 10
Closed Access | Times Cited: 435
Tumor Microenvironment as A “Game Changer” in Cancer Radiotherapy
Magdalena Jarosz‐Biej, Ryszard Smolarczyk, Tomasz Cichoń, et al.
International Journal of Molecular Sciences (2019) Vol. 20, Iss. 13, pp. 3212-3212
Open Access | Times Cited: 420
Magdalena Jarosz‐Biej, Ryszard Smolarczyk, Tomasz Cichoń, et al.
International Journal of Molecular Sciences (2019) Vol. 20, Iss. 13, pp. 3212-3212
Open Access | Times Cited: 420
Charged-particle therapy in cancer: clinical uses and future perspectives
Marco Durante, Roberto Orecchia, Jay S. Loeffler
Nature Reviews Clinical Oncology (2017) Vol. 14, Iss. 8, pp. 483-495
Closed Access | Times Cited: 416
Marco Durante, Roberto Orecchia, Jay S. Loeffler
Nature Reviews Clinical Oncology (2017) Vol. 14, Iss. 8, pp. 483-495
Closed Access | Times Cited: 416
Host STING-dependent MDSC mobilization drives extrinsic radiation resistance
Hua Liang, Liufu Deng, Yuzhu Hou, et al.
Nature Communications (2017) Vol. 8, Iss. 1
Open Access | Times Cited: 398
Hua Liang, Liufu Deng, Yuzhu Hou, et al.
Nature Communications (2017) Vol. 8, Iss. 1
Open Access | Times Cited: 398
Roles of PD-1/PD-L1 Pathway: Signaling, Cancer, and Beyond
Luoyan Ai, Antao Xu, Jie Xu
Advances in experimental medicine and biology (2020), pp. 33-59
Closed Access | Times Cited: 385
Luoyan Ai, Antao Xu, Jie Xu
Advances in experimental medicine and biology (2020), pp. 33-59
Closed Access | Times Cited: 385
Radiotherapy combined with immunotherapy: the dawn of cancer treatment
Zengfu Zhang, Xu Liu, Dawei Chen, et al.
Signal Transduction and Targeted Therapy (2022) Vol. 7, Iss. 1
Open Access | Times Cited: 359
Zengfu Zhang, Xu Liu, Dawei Chen, et al.
Signal Transduction and Targeted Therapy (2022) Vol. 7, Iss. 1
Open Access | Times Cited: 359
Recent advances in nanomaterial-based synergistic combination cancer immunotherapy
Wei Sang, Zhan Zhang, Yunlu Dai, et al.
Chemical Society Reviews (2019) Vol. 48, Iss. 14, pp. 3771-3810
Closed Access | Times Cited: 349
Wei Sang, Zhan Zhang, Yunlu Dai, et al.
Chemical Society Reviews (2019) Vol. 48, Iss. 14, pp. 3771-3810
Closed Access | Times Cited: 349
T Cell–Inflamed versus Non-T Cell–Inflamed Tumors: A Conceptual Framework for Cancer Immunotherapy Drug Development and Combination Therapy Selection
Jonathan Trujillo, Randy F. Sweis, Riyue Bao, et al.
Cancer Immunology Research (2018) Vol. 6, Iss. 9, pp. 990-1000
Open Access | Times Cited: 343
Jonathan Trujillo, Randy F. Sweis, Riyue Bao, et al.
Cancer Immunology Research (2018) Vol. 6, Iss. 9, pp. 990-1000
Open Access | Times Cited: 343
The linear quadratic model: usage, interpretation and challenges
Stephen J. McMahon
Physics in Medicine and Biology (2018) Vol. 64, Iss. 1, pp. 01TR01-01TR01
Open Access | Times Cited: 333
Stephen J. McMahon
Physics in Medicine and Biology (2018) Vol. 64, Iss. 1, pp. 01TR01-01TR01
Open Access | Times Cited: 333
Combining Immunotherapy and Radiotherapy for Cancer Treatment: Current Challenges and Future Directions
Yifan Wang, Weiye Deng, Nan Li, et al.
Frontiers in Pharmacology (2018) Vol. 9
Open Access | Times Cited: 332
Yifan Wang, Weiye Deng, Nan Li, et al.
Frontiers in Pharmacology (2018) Vol. 9
Open Access | Times Cited: 332
Neutrophil-Based Drug Delivery Systems
Dafeng Chu, Xinyue Dong, Xutong Shi, et al.
Advanced Materials (2018) Vol. 30, Iss. 22
Open Access | Times Cited: 315
Dafeng Chu, Xinyue Dong, Xutong Shi, et al.
Advanced Materials (2018) Vol. 30, Iss. 22
Open Access | Times Cited: 315
A framework for the development of effective anti-metastatic agents
Robin L. Anderson, Theo Balasas, Juliana Callaghan, et al.
Nature Reviews Clinical Oncology (2018) Vol. 16, Iss. 3, pp. 185-204
Open Access | Times Cited: 281
Robin L. Anderson, Theo Balasas, Juliana Callaghan, et al.
Nature Reviews Clinical Oncology (2018) Vol. 16, Iss. 3, pp. 185-204
Open Access | Times Cited: 281
Self-Supplied Tumor Oxygenation through Separated Liposomal Delivery of H2O2 and Catalase for Enhanced Radio-Immunotherapy of Cancer
Xuejiao Song, Jun Xu, Chao Liang, et al.
Nano Letters (2018) Vol. 18, Iss. 10, pp. 6360-6368
Closed Access | Times Cited: 266
Xuejiao Song, Jun Xu, Chao Liang, et al.
Nano Letters (2018) Vol. 18, Iss. 10, pp. 6360-6368
Closed Access | Times Cited: 266
Local biomaterials-assisted cancer immunotherapy to trigger systemic antitumor responses
Qian Chen, Muchao Chen, Zhuang Liu
Chemical Society Reviews (2019) Vol. 48, Iss. 22, pp. 5506-5526
Closed Access | Times Cited: 257
Qian Chen, Muchao Chen, Zhuang Liu
Chemical Society Reviews (2019) Vol. 48, Iss. 22, pp. 5506-5526
Closed Access | Times Cited: 257
Immunity, Hypoxia, and Metabolism–the Ménage à Trois of Cancer: Implications for Immunotherapy
Carla Riera‐Domingo, Annette Audigé, Sara Granja, et al.
Physiological Reviews (2019) Vol. 100, Iss. 1, pp. 1-102
Open Access | Times Cited: 252
Carla Riera‐Domingo, Annette Audigé, Sara Granja, et al.
Physiological Reviews (2019) Vol. 100, Iss. 1, pp. 1-102
Open Access | Times Cited: 252
Safety of combining radiotherapy with immune-checkpoint inhibition
William L. Hwang, Luke Pike, Trevor J. Royce, et al.
Nature Reviews Clinical Oncology (2018) Vol. 15, Iss. 8, pp. 477-494
Closed Access | Times Cited: 246
William L. Hwang, Luke Pike, Trevor J. Royce, et al.
Nature Reviews Clinical Oncology (2018) Vol. 15, Iss. 8, pp. 477-494
Closed Access | Times Cited: 246
NKG2D-Based CAR T Cells and Radiotherapy Exert Synergistic Efficacy in Glioblastoma
Tobias Weiß, Michael Weller, Matthias Gückenberger, et al.
Cancer Research (2017) Vol. 78, Iss. 4, pp. 1031-1043
Open Access | Times Cited: 241
Tobias Weiß, Michael Weller, Matthias Gückenberger, et al.
Cancer Research (2017) Vol. 78, Iss. 4, pp. 1031-1043
Open Access | Times Cited: 241
Nanotechnology Strategies To Advance Outcomes in Clinical Cancer Care
Christopher M. Hartshorn, Michelle S. Bradbury, Gregory M. Lanza, et al.
ACS Nano (2017) Vol. 12, Iss. 1, pp. 24-43
Open Access | Times Cited: 233
Christopher M. Hartshorn, Michelle S. Bradbury, Gregory M. Lanza, et al.
ACS Nano (2017) Vol. 12, Iss. 1, pp. 24-43
Open Access | Times Cited: 233
AIEgens for biological process monitoring and disease theranostics
Xinggui Gu, Ryan T. K. Kwok, Jacky W. Y. Lam, et al.
Biomaterials (2017) Vol. 146, pp. 115-135
Closed Access | Times Cited: 226
Xinggui Gu, Ryan T. K. Kwok, Jacky W. Y. Lam, et al.
Biomaterials (2017) Vol. 146, pp. 115-135
Closed Access | Times Cited: 226
Overcoming TGFβ-mediated immune evasion in cancer
Daniele V. F. Tauriello, Elena Sancho, Eduard Batlle
Nature reviews. Cancer (2021) Vol. 22, Iss. 1, pp. 25-44
Open Access | Times Cited: 223
Daniele V. F. Tauriello, Elena Sancho, Eduard Batlle
Nature reviews. Cancer (2021) Vol. 22, Iss. 1, pp. 25-44
Open Access | Times Cited: 223